2-[(1R,17R,22S,23R,24R,25S)-25-[2-(2-amino-4-pyridinyl)ethoxy]-4,23,24-trihydroxy-6,13-dioxo-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaen-17-yl]guanidine

C31H33N5O9 — CID 162842613

IUPAC2-[(1R,17R,22S,23R,24R,25S)-25-[2-(2-amino-4-pyridinyl)ethoxy]-4,23,24-trihydroxy-6,13-dioxo-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaen-17-yl]guanidine
SMILESNC(N)=N[C@@H]1CCOC[C@@H]2O[C@H](Oc3c1cc1c(c3O)C(=O)c3ccccc3C1=O)[C@@H](OCCc1ccnc(N)c1)[C@H](O)[C@H]2O
InChIInChI=1S/C31H33N5O9/c32-21-11-14(5-8-35-21)6-10-43-29-27(41)25(39)20-13-42-9-7-19(36-31(33)34)17-12-18-22(26(40)28(17)45-30(29)44-20)24(38)16-4-2-1-3-15(16)23(18)37/h1-5,8,11-12,19-20,25,27,29-30,39-41H,6-7,9-10,13H2,(H2,32,35)(H4,33,34,36)/t19-,20+,25+,27-,29+,30-/m1/s1
InChIKeyPAJXIKLNZZNAKY-NUZVVUDASA-N
MW619.63 g/mol
LogP0.33
Rot. Bonds5

About 2-[(1R,17R,22S,23R,24R,25S)-25-[2-(2-amino-4-pyridinyl)ethoxy]-4,23,24-trihydroxy-6,13-dioxo-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaen-17-yl]guanidine

2-[(1R,17R,22S,23R,24R,25S)-25-[2-(2-amino-4-pyridinyl)ethoxy]-4,23,24-trihydroxy-6,13-dioxo-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaen-17-yl]guanidine (PubChem CID 162842613) has the molecular formula C31H33N5O9 and a molecular weight of 619.63 g/mol. Its IUPAC name is 2-[(1R,17R,22S,23R,24R,25S)-25-[2-(2-amino-4-pyridinyl)ethoxy]-4,23,24-trihydroxy-6,13-dioxo-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaen-17-yl]guanidine.

Molecular Properties

Compound Name2-[(1R,17R,22S,23R,24R,25S)-25-[2-(2-amino-4-pyridinyl)ethoxy]-4,23,24-trihydroxy-6,13-dioxo-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaen-17-yl]guanidine
PubChem CID162842613
Molecular FormulaC31H33N5O9
Molecular Weight619.63 g/mol
Exact Mass619.23
IUPAC Name2-[(1R,17R,22S,23R,24R,25S)-25-[2-(2-amino-4-pyridinyl)ethoxy]-4,23,24-trihydroxy-6,13-dioxo-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaen-17-yl]guanidine
SMILESNC(N)=N[C@@H]1CCOC[C@@H]2O[C@H](Oc3c1cc1c(c3O)C(=O)c3ccccc3C1=O)[C@@H](OCCc1ccnc(N)c1)[C@H](O)[C@H]2O
InChIInChI=1S/C31H33N5O9/c32-21-11-14(5-8-35-21)6-10-43-29-27(41)25(39)20-13-42-9-7-19(36-31(33)34)17-12-18-22(26(40)28(17)45-30(29)44-20)24(38)16-4-2-1-3-15(16)23(18)37/h1-5,8,11-12,19-20,25,27,29-30,39-41H,6-7,9-10,13H2,(H2,32,35)(H4,33,34,36)/t19-,20+,25+,27-,29+,30-/m1/s1
InChIKeyPAJXIKLNZZNAKY-NUZVVUDASA-N
XLogP0.33
TPSA235.06 Ų
H-Bond Donors6
H-Bond Acceptors12
Rotatable Bonds5
Heavy Atoms45
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500619.63
LogP ≤ 50.33
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1012

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'quinone_A(370)', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}

Analyze 2-[(1R,17R,22S,23R,24R,25S)-25-[2-(2-amino-4-pyridinyl)ethoxy]-4,23,24-trihydroxy-6,13-dioxo-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaen-17-yl]guanidine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[(1R,17R,22S,23R,24R,25S)-25-[2-(2-amino-4-pyridinyl)ethoxy]-4,23,24-trihydroxy-6,13-dioxo-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaen-17-yl]guanidine?
The IUPAC name of 2-[(1R,17R,22S,23R,24R,25S)-25-[2-(2-amino-4-pyridinyl)ethoxy]-4,23,24-trihydroxy-6,13-dioxo-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaen-17-yl]guanidine (CID 162842613) is 2-[(1R,17R,22S,23R,24R,25S)-25-[2-(2-amino-4-pyridinyl)ethoxy]-4,23,24-trihydroxy-6,13-dioxo-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaen-17-yl]guanidine.
What is the SMILES notation for 2-[(1R,17R,22S,23R,24R,25S)-25-[2-(2-amino-4-pyridinyl)ethoxy]-4,23,24-trihydroxy-6,13-dioxo-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaen-17-yl]guanidine?
The canonical SMILES for 2-[(1R,17R,22S,23R,24R,25S)-25-[2-(2-amino-4-pyridinyl)ethoxy]-4,23,24-trihydroxy-6,13-dioxo-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaen-17-yl]guanidine is NC(N)=N[C@@H]1CCOC[C@@H]2O[C@H](Oc3c1cc1c(c3O)C(=O)c3ccccc3C1=O)[C@@H](OCCc1ccnc(N)c1)[C@H](O)[C@H]2O.
What is the InChIKey of 2-[(1R,17R,22S,23R,24R,25S)-25-[2-(2-amino-4-pyridinyl)ethoxy]-4,23,24-trihydroxy-6,13-dioxo-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaen-17-yl]guanidine?
The InChIKey is PAJXIKLNZZNAKY-NUZVVUDASA-N. The full InChI is InChI=1S/C31H33N5O9/c32-21-11-14(5-8-35-21)6-10-43-29-27(41)25(39)20-13-42-9-7-19(36-31(33)34)17-12-18-22(26(40)28(17)45-30(29)44-20)24(38)16-4-2-1-3-15(16)23(18)37/h1-5,8,11-12,19-20,25,27,29-30,39-41H,6-7,9-10,13H2,(H2,32,35)(H4,33,34,36)/t19-,20+,25+,27-,29+,30-/m1/s1.
What are the key properties of 2-[(1R,17R,22S,23R,24R,25S)-25-[2-(2-amino-4-pyridinyl)ethoxy]-4,23,24-trihydroxy-6,13-dioxo-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaen-17-yl]guanidine?
2-[(1R,17R,22S,23R,24R,25S)-25-[2-(2-amino-4-pyridinyl)ethoxy]-4,23,24-trihydroxy-6,13-dioxo-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaen-17-yl]guanidine has a molecular weight of 619.63 g/mol, XLogP of 0.33, 5 rotatable bonds, 6 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[(1R,17R,22S,23R,24R,25S)-25-[2-(2-amino-4-pyridinyl)ethoxy]-4,23,24-trihydroxy-6,13-dioxo-2,20,26-trioxapentacyclo[20.3.1.03,16.05,14.07,12]hexacosa-3,5(14),7,9,11,15-hexaen-17-yl]guanidine is sourced from PubChem (CID 162842613), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).